EUVIMEDEUVIMED entdecken
Crossref

Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS Standards

Robert D Siegel, Kristine B LeFebvre, Sarah Temin, Amy Evers, Lisa Barbarotta, Ronda M Bowman, Alexandre Chan, David W Dougherty, Michael Ganio, Therese Marie Mulvey, Amanda Ouzts, Martha Polovich und 5 weitere

Oncology Nursing Forum · 01.07.2024

DOI: 10.1188/24.onf.297-320 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Nursing Forum, online erschienen am 02.07.2024. Verfasst von Robert D Siegel und 16 weiteren Autor:innen. Beteiligte Einrichtung: Bon Secours St Francis Cancer Center. Hauptthemen laut MEDLINE: Antineoplastic Agents, Oncology Nursing, Neoplasms, Patient Safety. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To update the American Society of Clinical Oncology (ASCO)-Oncology Nursing Society (ONS) standards for antineoplastic therapy administration safety in adult and pediatric oncology and highlight current standards for antineoplastic therapy for adult and pediatric populations with various routes of administration and location. METHODS: ASCO and ONS convened a multidisciplinary Expert Panel with representation of multiple organizations to conduct literature reviews and add to the standards as needed. The evidence base was combined with the opinion of the ASCO-ONS Expert Panel to develop antineoplastic safety standards and guidance. Public comments were solicited and considered in preparation of the final manuscript. RESULTS: The standards presented here include clarification and expansion of existing standards to include home administration and other changes in processes of ordering, preparing, and administering antineoplastic therapy; the advent of immune effector cellular therapy; the importance of social determinants of health; fertility preservation; and pregnancy avoidance. In addition, the standards have added a fourth verification. STANDARDS: Standards are provided for which health care organizations and those involved in all aspects of patient care can safely deliver antineoplastic therapy, increase the quality of care, and reduce medical errors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsOncology NursingNeoplasmsPatient SafetyHumansAdultChildFemaleUnited StatesMaleSocieties, Nursing

Stichwörter der Autor:innen

antineoplastic therapy administrationguidelinesoncologysafetystandards

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Bon Secours St Francis Cancer Center.
  • Oncology Nursing Society.
  • American Society of Clinical Oncology.
  • University of Pennsylvania Health System.
  • Smilow Cancer Hospital and Yale Cancer Center.
  • University of California, Irvine.

Zitieren

APA

Siegel, R. D., LeFebvre, K. B., Temin, S., Evers, A., Barbarotta, L., Bowman, R. M., Chan, A., Dougherty, D. W., Ganio, M., Mulvey, T. M., Ouzts, A., Polovich, M., Salazar-Abshire, M., Stenstrup, Z., Sydenstricker, C. M., Tsai, S., & Olsen, M. (2024). Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS Standards. Oncology Nursing Forum. https://doi.org/10.1188/24.onf.297-320

Vancouver

Siegel RD, LeFebvre KB, Temin S, Evers A, Barbarotta L, Bowman RM, et al. Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS Standards. Oncology Nursing Forum. 2024. doi:10.1188/24.onf.297-320

BibTeX
@article{Siegel2024,
  author = {Siegel, Robert D and LeFebvre, Kristine B and Temin, Sarah and Evers, Amy and Barbarotta, Lisa and Bowman, Ronda M and Chan, Alexandre and Dougherty, David W and Ganio, Michael and Mulvey, Therese Marie and Ouzts, Amanda and Polovich, Martha and Salazar-Abshire, Maritza and Stenstrup, Elaine and Sydenstricker, Christine Marie and Tsai, Susan and Olsen, MiKaela},
  title = {Antineoplastic Therapy Administration Safety Standards for Adult and Pediatric Oncology: ASCO-ONS Standards},
  journal = {Oncology Nursing Forum},
  year = {2024},
  doi = {10.1188/24.onf.297-320}
}
Kostenlos starten →